Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reduced-dose Radiotherapy for Stage III Nasopharyngeal Carcinoma Based on the Treatment Response: an Open Label, Non-Inferiority, Multicenter, Randomized Phase 3 Trial

NCT06239727 is registered in ClinicalTrials.gov with Sun Yat-sen University as lead sponsor.

NCT NCT06239727
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06239727 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reduced-dose Radiotherapy for Stage III Nasopharyngeal Carcinoma Based on the Treatment Response: an Open Label, Non-Inferiority, Multicenter, Randomized Phase 3 Trial
Lead sponsor
Sun Yat-sen University
Phase
Phase 3
Overall status
Recruiting
Start date
March 1, 2024
Completion date
February 20, 2030
Enrollment
593 (estimated)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

nasopharyngeal carcinoma